IOPAMIDOL

Iopamidol Adverse Events Reported to the FDA Over Time

How are Iopamidol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Iopamidol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Iopamidol is flagged as the suspect drug causing the adverse event.

Most Common Iopamidol Adverse Events Reported to the FDA

What are the most common Iopamidol adverse events reported to the FDA?

Anaphylactic Shock	93 (3.17%)
Blood Pressure Decreased	62 (2.11%)
Vomiting	58 (1.98%)
Nausea	57 (1.94%)
Loss Of Consciousness	54 (1.84%)
Dyspnoea	46 (1.57%)
Shock	46 (1.57%)
Pyrexia	43 (1.47%)
Respiratory Arrest	36 (1.23%)
Cardiac Arrest	35 (1.19%)
Contrast Media Reaction	35 (1.19%)
	Show More
Anaphylactic Reaction	34 (1.16%)
Cardio-respiratory Arrest	34 (1.16%)
Feeling Abnormal	32 (1.09%)
Toxic Skin Eruption	29 (.99%)
Depressed Level Of Consciousness	28 (.95%)
Rash	26 (.89%)
Erythema	25 (.85%)
Atrial Fibrillation	24 (.82%)
Convulsion	24 (.82%)
Hypersensitivity	23 (.78%)
Nephropathy Toxic	21 (.72%)
Septic Shock	21 (.72%)
Cerebral Infarction	20 (.68%)
Oxygen Saturation Decreased	20 (.68%)
Renal Failure Acute	20 (.68%)
Cardiac Failure	19 (.65%)
Toxic Epidermal Necrolysis	19 (.65%)
Erythema Multiforme	18 (.61%)
General Physical Health Deteriorati...	18 (.61%)
Renal Impairment	18 (.61%)
Extravasation	17 (.58%)
Headache	17 (.58%)
Pruritus	17 (.58%)
Acute Generalised Exanthematous Pus...	16 (.55%)
Condition Aggravated	16 (.55%)
Contrast Media Allergy	16 (.55%)
Eosinophil Count Increased	16 (.55%)
Blood Creatinine Increased	15 (.51%)
Injection Site Extravasation	15 (.51%)
Acute Respiratory Distress Syndrome	14 (.48%)
Gastrointestinal Perforation	14 (.48%)
Hypotension	14 (.48%)
Pleural Effusion	14 (.48%)
Pulmonary Oedema	14 (.48%)
Urticaria	14 (.48%)
Blood Pressure Increased	13 (.44%)
Bradycardia	13 (.44%)
Renal Failure	13 (.44%)
Restlessness	13 (.44%)
Altered State Of Consciousness	12 (.41%)
Anaphylactoid Reaction	12 (.41%)
Cyanosis	12 (.41%)
Flushing	12 (.41%)
Myocardial Infarction	12 (.41%)
Stevens-johnson Syndrome	12 (.41%)
Anaphylactoid Shock	11 (.38%)
Blood Pressure Immeasurable	11 (.38%)
Chest Pain	11 (.38%)
Haematemesis	11 (.38%)
Haemoglobin Decreased	11 (.38%)
Hyperhidrosis	11 (.38%)
Liver Disorder	11 (.38%)
Post Procedural Complication	11 (.38%)
Ventricular Fibrillation	11 (.38%)
Amnesia	10 (.34%)
Central Nervous System Lesion	10 (.34%)
Cough	10 (.34%)
Heart Rate Increased	10 (.34%)
Nervous System Disorder	10 (.34%)
Off Label Use	10 (.34%)
Oropharyngeal Pain	10 (.34%)
Pharyngeal Oedema	10 (.34%)
Angioedema	9 (.31%)
Asthenia	9 (.31%)
C-reactive Protein Increased	9 (.31%)
Choking Sensation	9 (.31%)
Drug Hypersensitivity	9 (.31%)
Laryngeal Oedema	9 (.31%)
Malaise	9 (.31%)
Medication Error	9 (.31%)
Unresponsive To Stimuli	9 (.31%)
Vertigo	9 (.31%)
Arteriospasm Coronary	8 (.27%)
Cardiac Failure Acute	8 (.27%)
Chills	8 (.27%)
Death	8 (.27%)
Hypertension	8 (.27%)
Intestinal Mucosal Hypertrophy	8 (.27%)
Pain In Extremity	8 (.27%)
Pallor	8 (.27%)
Pharyngeal Erythema	8 (.27%)
Platelet Count Increased	8 (.27%)
Procedural Complication	8 (.27%)
Pulse Absent	8 (.27%)
Purpura	8 (.27%)
Rash Generalised	8 (.27%)
Ventricular Tachycardia	8 (.27%)
Blood Blister	7 (.24%)
Bronchospasm	7 (.24%)
Coma	7 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Iopamidol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Iopamidol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Iopamidol

What are the most common Iopamidol adverse events reported to the FDA?

Epidermal And Dermal Conditions	236 (8.05%)
Allergic Conditions	200 (6.82%)
Respiratory	182 (6.21%)
Neurological	176 (6%)
Cardiac Arrhythmias	149 (5.08%)
Cardiac And Vascular Investigations	126 (4.3%)
Gastrointestinal Signs	125 (4.26%)
Decreased And Nonspecific Blood Pre...	64 (2.18%)
Procedural And Device Related Injur...	64 (2.18%)
Renal Disorders	63 (2.15%)
Hematology Investigations	54 (1.84%)
	Show More
Infections - Pathogen Unspecified	50 (1.7%)
Seizures	49 (1.67%)
Body Temperature Conditions	47 (1.6%)
Lower Respiratory Tract Disorders	47 (1.6%)
Administration Site Reactions	45 (1.53%)
Coronary Artery	45 (1.53%)
Central Nervous System Vascular	44 (1.5%)
Hepatic And Hepatobiliary	35 (1.19%)
Heart Failures	34 (1.16%)
Metabolic, Nutritional And Blood Ga...	34 (1.16%)
Upper Respiratory Tract Disorders	32 (1.09%)
Nephropathies	30 (1.02%)
Vascular	26 (.89%)
Movement Disorders	25 (.85%)
Bronchial Disorders	24 (.82%)
Medication Errors	24 (.82%)
Angiedema And Urticaria	23 (.78%)
Ocular Infections, Irritations And ...	21 (.72%)
Gastrointestinal Ulceration And Per...	20 (.68%)
Pleural	20 (.68%)
Renal And Urinary Tract Investigati...	20 (.68%)
Musculoskeletal And Connective Tiss...	19 (.65%)
Cardiac Disorder Signs	18 (.61%)
Mental Impairment	18 (.61%)
Oral Soft Tissue Conditions	18 (.61%)
Headaches	17 (.58%)
Eye	16 (.55%)
Hepatobiliary	16 (.55%)
Ocular Neuromuscular	16 (.55%)
Skin Vascular Abnormalities	16 (.55%)
Skin Appendage Conditions	15 (.51%)
Injuries	14 (.48%)
Changes In Physical Activity	13 (.44%)
Enzyme	13 (.44%)
Vascular Hypertensive	13 (.44%)
Gastrointestinal Hemorrhages	12 (.41%)
Hematological And Lymphoid Tissue T...	12 (.41%)
Muscle	12 (.41%)
Ocular Sensory Symptoms	12 (.41%)
Gastrointestinal Motility And Defec...	11 (.38%)
Therapeutic Procedures And Supporti...	11 (.38%)
Vision	11 (.38%)
Appetite And General Nutritional	10 (.34%)
Deliria	10 (.34%)
Protein And Chemistry Analyses	10 (.34%)
Fatal Outcomes	9 (.31%)
Inner Ear And Viiith Cranial Nerve	9 (.31%)
Therapeutic And Nontherapeutic Effe...	9 (.31%)
Gastrointestinal Conditions	8 (.27%)
Immunology And Allergy	8 (.27%)
Urinary Tract Signs	8 (.27%)
Bacterial Infectious	7 (.24%)
Electrolyte And Fluid Balance Condi...	7 (.24%)
Platelet	7 (.24%)
Skin And Subcutaneous Tissue	7 (.24%)
Aneurysms And Artery Dissections	6 (.2%)
Bone Disorders	6 (.2%)
Central Nervous System Infections A...	6 (.2%)
Cranial Nerve Disorders	6 (.2%)
Increased Intracranial Pressure And...	6 (.2%)
Peritoneal And Retroperitoneal Cond...	6 (.2%)
Spleen, Lymphatic And Reticulendoth...	6 (.2%)
Water, Electrolyte And Mineral	6 (.2%)
Anemias Nonhemolytic And Marrow Dep...	5 (.17%)
Arteriosclerosis, Stenosis, Vascula...	5 (.17%)
Bone, Calcium, Magnesium And Phosph...	5 (.17%)
Coagulopathies And Bleeding Diathes...	5 (.17%)
Investigations, Imaging And Histopa...	5 (.17%)
Neurological, Special Senses And Ps...	5 (.17%)
Pulmonary Vascular	5 (.17%)
Respiratory And Pulmonary Investiga...	5 (.17%)
Spinal Cord And Nerve Root	5 (.17%)
Anxiety Disorders	4 (.14%)
Exocrine Pancreas Conditions	4 (.14%)
Gastrointestinal Neoplasms Malignan...	4 (.14%)
Joint	4 (.14%)
Ocular Hemorrhages And Vascular	4 (.14%)
Physical Examination Topics	4 (.14%)
Vascular Hemorrhagic	4 (.14%)
White Blood Cell	4 (.14%)
Chemical Injury And Poisoning	3 (.1%)
Encephalopathies	3 (.1%)
Fungal Infectious	3 (.1%)
Hematological	3 (.1%)
Neuromuscular	3 (.1%)
Psychiatric And Behavioural Symptom...	3 (.1%)
Reproductive Tract	3 (.1%)
Tendon, Ligament And Cartilage	3 (.1%)
Acid-base	2 (.07%)
Cardiac And Vascular Disorders Cong...	2 (.07%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Iopamidol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Iopamidol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.